CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Operating activities:
Net income (loss)	$ (41,980)	$ 70,512
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Amortization and impairment of software development costs and licenses	117,158	123,345
Depreciation and amortization	9,383	11,271
Loss from discontinued operations	285	5,708
Amortization and impairment of intellectual property	979	2,796
Stock-based compensation	23,463	23,630
Deferred income taxes		1,491
Amortization of discount on Convertible Notes	7,294	5,440
Amortization of debt issuance costs	1,014	939
Other, net	778	(525)
Changes in assets and liabilities, net of effect from purchases of businesses:
Accounts receivable	30,943	(9,710)
Inventory	2,062	(4,113)
Software development costs and licenses	(147,315)	(118,961)
Prepaid expenses, other current and other non-current assets	4,125	11,987
Deferred revenue	(1,640)	(1,532)
Accounts payable, accrued expenses, income taxes payable and other liabilities	(59,574)	42,063
Net cash used in discontinued operations	(1,580)	(9,170)
Net cash (used in) provided by operating activities	(54,605)	155,171
Investing activities:
Purchase of fixed assets	(7,984)	(8,246)
Settlement of purchase price related to discontinued operations	(1,475)
Cash received from sale of business		3,075
Payments in connection with business combinations, net of cash acquired		(1,000)
Net cash used in investing activities	(9,459)	(6,171)
Financing activities:
Proceeds from exercise of employee stock options	238	104
Proceeds from issuance of Convertible Notes	250,000
Payment of debt issuance costs	(6,875)
Net cash provided by financing activities	243,363	104
Effects of exchange rates on cash and cash equivalents	(6,342)	2,176
Net increase in cash and cash equivalents	172,957	151,280
Cash and cash equivalents, beginning of year	280,359	145,838
Cash and cash equivalents, end of period	$ 453,316	$ 297,118